Epithelioid hemangioendothelioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our report provides the first case of intracranial EHE with molecular proof of WWTR1-CAMTA1 gene fusion.
|
30085199 |
2018 |
Epithelioid hemangioendothelioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In addition, a recurrent YAP1-TFE3 gene fusion has been identified in WWTR1-CAMTA1 negative epithelioid hemangioendotheliomas.
|
25680571 |
2015 |
Epithelioid hemangioendothelioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Conventional epithelioid hemangioendotheliomas (EHE) have a distinctive morphologic appearance and are characterized by a recurrent t(1;3) translocation, resulting in a WWTR1-CAMTA1 fusion gene.
|
23737213 |
2013 |
Epithelioid hemangioendothelioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study confirms the high incidence of WWTR1-CAMTA1 and YAP1-TFE3 rearrangements in EHE and indicates that the staining pattern for TFE3 IHC is critical for specificity.
|
25817592 |
2015 |
Epithelioid hemangioendothelioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, we observed CAMTA1 gene break-apart in all of the five TFE3-positive EHEs via FISH assays, and four out of the five TFE3-positive EHEs exhibited WWTR1-CAMTA1 gene fusions via RT-PCR.
|
26840265 |
2016 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
In 18 patients (15 with WWTR1-CAMTA1 and 3 with YAP1-TFE3) Memorial Sloan Kettering-IMPACT targeted DNA sequencing was performed to identify secondary genetic alterations showing more than half of tumors had a genetic alteration beyond the disease-defining gene fusion.
|
31537895 |
2019 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The translocation t(1;3)(p36.3;q25), resulting in the CAMTA1- WWTR1 fusion product, is the most commonly identified genetic abnormality with this tumor.
|
29372848 |
2018 |
Epithelioid hemangioendothelioma, malignant
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study confirms the high incidence of WWTR1-CAMTA1 and YAP1-TFE3 rearrangements in EHE and indicates that the staining pattern for TFE3 IHC is critical for specificity.
|
25817592 |
2015 |
Epithelioid hemangioendothelioma, malignant
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our report provides the first case of intracranial EHE with molecular proof of WWTR1-CAMTA1 gene fusion.
|
30085199 |
2018 |
Carcinogenesis
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
In this study, we provided evidence that constitutively active TAZ (TAZ-S89A) is a driver for lung tumorigenesis in vivo in mice and formation of lung CSC.
|
28415606 |
2017 |
Childhood Epithelioid Hemangioendothelioma
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Our report provides the first case of intracranial EHE with molecular proof of WWTR1-CAMTA1 gene fusion.
|
30085199 |
2018 |
Adult Epithelioid Hemangioendothelioma
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Our report provides the first case of intracranial EHE with molecular proof of WWTR1-CAMTA1 gene fusion.
|
30085199 |
2018 |
Neoplasms, Vascular Tissue
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
|
25353289 |
2015 |
Osteogenesis Imperfecta
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We report that combinatorial YAP/TAZ deletion from skeletal lineage cells, using Osterix-Cre, caused an osteogenesis imperfecta-like phenotype with severity dependent on allele dose and greater phenotypic expressivity with homozygous TAZ vs. YAP ablation.
|
29401582 |
2018 |
Thyroid Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.
|
27026033 |
2016 |
Thyroid Dysgenesis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.
|
19542741 |
2009 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Genetic studies also led to the finding that WWTR1-CAMTA1 fusions are useful diagnostic markers for epithelioid hemangioendotheliomas, which can present as pleural-based masses.
|
26811225 |
2016 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Characterization of the genetics of EHE is important because targeted therapies toward products of the specific WWTR1-CAMTA1 gene fusion may have an impact in the near future.
|
28855107 |
2018 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
A WWTR1-CAMTA1 fusion is present in most classic epithelioid hemangioendothelioma, regardless of their clinical behavior, suggesting that additional genetic abnormalities might be responsible in driving a more aggressive biology.
|
31537895 |
2019 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Instead, WWTR1-CAMTA1 and YAP1-TFE3 fusion genes are found in almost all cases of epithelioid haemangioendothelioma.
|
26050962 |
2015 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The WWTR1 (protein is known as TAZ)-CAMTA1 (WC) fusion gene defines epithelioid hemangioendothelioma, a malignant vascular cancer.
|
25961935 |
2016 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Thus, we undertook a molecular analysis of six samples from two patients with multicentric hepatic EHE to test our hypothesis that the presence of identical breakpoints in WWTR1 and CAMTA1 support the monoclonal nature of multifocal EHE.
|
22429593 |
2012 |
Epithelioid hemangioendothelioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Fluorescence in situ hybridization analysis showed CAMTA1-WWTR1 fusions in 4/7 low-grade and 23/23 intermediate-grade EHE (P<0.001).
|
25353289 |
2015 |